Literature DB >> 24856111

Lathyrane-type diterpenoids from the seeds of Euphorbia lathyris.

Jin Lu1, Guoyu Li2, Jian Huang3, Cui Zhang1, Lan Zhang1, Ke Zhang2, Pingya Li4, Ruichao Lin5, Jinhui Wang6.   

Abstract

Ten lathyrane-type diterpenoids named Euphorbia Factor L12-L21 (1-10) and twelve known diterpenoids (11-22) were isolated from seeds of Euphorbia lathyris. The structures of these compounds were determined by extensive spectroscopic (UV, IR, HRESIMS, 1D and 2D NMR) analyses. In addition, the configuration of Euphorbia Factor L12 (1) was further confirmed by X-ray crystallographic and circular dichroism (CD) analyses. A putative biogenetic relationship to these compounds was proposed. Cytotoxicity of the isolated compounds against C6 and MCF-7 cell lines were evaluated. Compounds 1, 5, 7, 12 and 17 exhibited considerable cytotoxic activities (IC50 12.4-36.2 μM).
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cytotoxicity; Euphorbia Factor L(12)–L(21); Euphorbia lathyris; Euphorbiaceae; Lathyrane-type diterpenoid

Mesh:

Substances:

Year:  2014        PMID: 24856111     DOI: 10.1016/j.phytochem.2014.04.020

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  9 in total

1.  Euphorbia factor L2 induces apoptosis in A549 cells through the mitochondrial pathway.

Authors:  Minting Lin; Sili Tang; Chao Zhang; Hubiao Chen; Wenjing Huang; Yun Liu; Jianye Zhang
Journal:  Acta Pharm Sin B       Date:  2016-07-30       Impact factor: 11.413

2.  Structure Identification and In Vitro Anticancer Activity of Lathyrol-3-phenylacetate-5,15-diacetate.

Authors:  Jian-Ye Zhang; Wen-Jing Huang; Hong-Mei Sun; Yun Liu; Xiao-Qin Zhao; Si-Li Tang; Ming-Na Sun; Sheng Wang; Jia-Jun Li; Ling-Ling Zhang; Jun-Hua Zhou; Qian-Rong Pan; Hu-Biao Chen
Journal:  Molecules       Date:  2017-08-25       Impact factor: 4.411

3.  Phytochemicals of Euphorbia lathyris L. and Their Antioxidant Activities.

Authors:  Lizhen Zhang; Chu Wang; Qiuxia Meng; Qin Tian; Yu Niu; Wei Niu
Journal:  Molecules       Date:  2017-08-18       Impact factor: 4.411

4.  Antitumor Effect of the Ethanolic Extract from Seeds of Euphorbia lathyris in Colorectal Cancer.

Authors:  Cristina Mesas; Rosario Martínez; Raúl Ortíz; Milagros Galisteo; María López-Jurado; Laura Cabeza; Gloria Perazzoli; Consolación Melguizo; Jesús M Porres; Jose Prados
Journal:  Nutrients       Date:  2021-02-09       Impact factor: 5.717

Review 5.  Pharmacological Potential of Lathyrane-Type Diterpenoids from Phytochemical Sources.

Authors:  Fátima Vela; Abdellah Ezzanad; Alan Christy Hunter; Antonio José Macías-Sánchez; Rosario Hernández-Galán
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-23

6.  Mechanism of action of cytotoxic compounds from the seeds of Euphorbia lathyris.

Authors:  Yu-Ning Teng; Yingzi Wang; Pei-Ling Hsu; Guang Xin; Yu Zhang; Susan L Morris-Natschke; Masuo Goto; Kuo-Hsiung Lee
Journal:  Phytomedicine       Date:  2018-02-02       Impact factor: 5.340

7.  Lathyrane Diterpenoids as Novel hPXR Agonists: Isolation, Structural Modification, and Structure-Activity Relationships.

Authors:  Dong Huang; Rui-Min Wang; Wei Li; Ying-Yuan Zhao; Fang-Yu Yuan; Xue-Long Yan; Ye Chen; Gui-Hua Tang; Hui-Chang Bi; Sheng Yin
Journal:  ACS Med Chem Lett       Date:  2021-06-25       Impact factor: 4.632

Review 8.  Euphorbia-Derived Natural Products with Potential for Use in Health Maintenance.

Authors:  Bahare Salehi; Marcello Iriti; Sara Vitalini; Hubert Antolak; Ewelina Pawlikowska; Dorota Kręgiel; Javad Sharifi-Rad; Sunday I Oyeleye; Adedayo O Ademiluyi; Katarzyna Czopek; Mariola Staniak; Luísa Custódio; Ericsson Coy-Barrera; Antonio Segura-Carretero; María de la Luz Cádiz-Gurrea; Raffaele Capasso; William C Cho; Ana M L Seca
Journal:  Biomolecules       Date:  2019-08-02

9.  Dual-Target Peptide-Modified Erythrocyte Membrane-Enveloped PLGA Nanoparticles for the Treatment of Glioma.

Authors:  Yuexin Cui; Jiejie Sun; Wenyan Hao; Mengyu Chen; Yingzi Wang; Fenghua Xu; Chunsheng Gao
Journal:  Front Oncol       Date:  2020-10-21       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.